Back

Proteomic profiling of circulating exosome identifies CAPG as a key molecule associated with clinical outcomes in heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of heart failure: emerging evidence Pathophysiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Satoshi Okochi

Fukushima Medical University, Fukushima (Japan)

5 More presentations in this session

Presentation thumbnail
Cardiac amyloidosis and heart failure phenotypes: a prognostic study of systolic function markers
Assistant Professor A. Zaroui (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
The impact of left ventricular reverse remodeling on asymptomatic structual heart disease
Doctor K. Tanaka (Niigata, JP)
Abstract Slides Video
Presentation thumbnail
Impact of obesity and breathlessness on MACE outcomes within HFpEF: results from the UK Biobank
Doctor M. Mahmod (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Mismatch between lead I from the 12-Lead ECG and smartwatch ECG: can AI models adapt for left ventricular systolic dysfunction prediction?
Mr J. Jang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Identification of biomarkers for right ventricular dysfunction in dilated cardiomyopathy using urinary proteomics and machine learning
Doctor J. Zhang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of heart failure: emerging evidence
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Plasma proteomics in acute heart failure - a step towards a mechanistic understanding of the disease
thumbnail
Congress Presentation
Proteome profiling by high-resolution mass spectrometry discriminates HFimpEF from HFrEF: a cohort-based biomarker discovery study
thumbnail
Congress Presentation
Serum exosomal microRNAs in patients with heart failure are correlated with myocardial DNA damage and future reverse remodeling

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources